University, MS, United States of America

Mark T Hamann


Average Co-Inventor Count = 1.8

ph-index = 1

Forward Citations = 20(Granted Patents)


Location History:

  • Oxford, MS (US) (2012)
  • University, MS (US) (2005 - 2014)
  • Mount Pleasant, SC (US) (2022)

Company Filing History:


Years Active: 2005-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mark T. Hamann: Innovator in Pharmaceutical Chemistry

Introduction

Mark T. Hamann, based in University, Mississippi, is a prominent inventor known for his significant contributions to pharmaceutical chemistry. With a total of four patents to his name, his research focuses on the discovery of novel compounds with therapeutic applications, particularly in the field of oncology and antibacterial agents.

Latest Patents

One of Mark T. Hamann's notable patents includes the development of synthetic novel pyrroloiminoquinone alkaloid, specifically Aleutianamine. This compound represents the first in a new class of pyrroloiminoquinone alkaloids, characterized by a highly strained multi-bridged ring system. Aleutianamine was discovered from a specimen collected during a NOAA deep-water exploration of the Aleutian Islands and has demonstrated potent and selective cytotoxicity toward various solid tumor cell lines, including pancreatic cancer (PANC-1) and colon cancer (H116).

Additionally, he has contributed to the creation of kaempferol-3-(2-E,3-Z-di-p-coumaroyl)-rhamnoside, kaempferol-3-(2-Z-3-E-di-p-coumaroyl)-rhamnoside, and kaempferol-3-(2,3-di-Z-p-coumaroyl)-rhamnoside, which are promising as a new class of antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).

Career Highlights

Throughout his career, Mark T. Hamann has gained extensive experience working at the University of Mississippi, where his research and innovations have been integral to advancements in medicinal chemistry. His work has focused on isolating and characterizing compounds that have the potential to lead to new treatments for diseases that are often resistant to conventional therapies.

Collaborations

Hamann's research efforts have been supported by a collaborative team, including notable coworkers such as Anna J. Kochanowska and Abir El-Alfy. Their combined expertise has facilitated the successful pursuit of groundbreaking research and the development of innovative therapeutic solutions.

Conclusion

Mark T. Hamann's contributions to the field of pharmaceutical chemistry highlight the importance of innovative research in combating diseases. His pioneering work in discovering new compounds with significant therapeutic potentials sets a strong foundation for future advancements in medicine, showcasing the vital role of inventors in driving innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…